€13.50 – €34.90
Huperzine-A 1% – pure powder. No additives.
SKU: huperzine-a-powder
ACTIVE INGREDIENT: Huperzine A 1%
ADDITIONAL INGREDIENTS: –
OTHER NAMES: huperzine A; huperzine A, (5alpha,9beta,11Z)-(-)-isomer; fordine
CAS NUMBER: 102518-79-6
ATC CODE: N06
FORMULA: C15H18N2O
MOLAR MASS: 242.322 g·mol−1
ITEM TYPE: Powder
QUANTITY PER PACK: 100 milligrams, 250 milligrams, 500 milligrams, 1 gram
SERVINGS PER PACK: –
SUGGESTED USE: –
STORAGE: Store in a cool and dry place. Keep away from direct sunlight and heat.
WARNING: Keep out of reach of children. Do not take this or any other supplement if under the age of 18, pregnant or nursing a baby, or if you have any known or suspected medical conditions, and/or taking prescription drugs or over the counter medications.
DISCLAIMER: Always consult with a qualified health physician before taking any new dietary supplement. This product is not intended to diagnose, treat, cure, or prevent any diseases.
SCOOPS: This product includes a measuring scoop (black) = 3,5 mg (approximately).
The product is not intended for human use. For laboratory use only.
Huperzine-A is a compound extracted from the herbs of the Huperziceae family. It is essentially an acetylcholinesterase inhibitor – it prevents that enzyme from breaking down acetylcholine, thus increasing the amount of this neurotransmitter.
Huperzine-A supports brain cell mitochondria, protecting them from free radical damage by acting as an antioxidant. It also bolsters neuron resistance to beta-amyloid induced dysfunction that could potentially lead to neurodegenerative diseases. Moreover, by acting as an NMDA receptor antagonist, it prevents glutamate excitotoxicity which has been associated with brain cell degeneration. Huperzine A also boosts the synthesis of NGF (nerve growth factor) which plays a critical role in brain cell development, maintenance and repair.
Products that combine huperzine A with certain drugs used for treating Alzheimer’s disease are being studied for their efficacy, as they might potentially have comparable therapeutic benefits at lower doses and, therefore, cause fewer side effects.
Huperzine A is often used by patients with Myasthenia Gravis.
Based on animal and human studies, huperzine A can be considered safe. It is generally well tolerated, with rarely any side effects at dosages routinely supplemented with.
Huperzine A can be toxic when used above the recommended dose range, or in individuals with high acetylcholine levels.
Side effects of huperzine A are rare, but they resemble the symptoms of choline overload.
Those suffering from heart disease as well as those who take drugs used for treating Alzheimer’s disease should consult their doctor before using Huperzine A.
Popular nootropic supplements NAC and NACET possess acetylcholinesterase inhibitor properties, so their concomitant use requires special caution, and perhaps a dosage adjustment.
Huperzine A is taken orally, and the standard dose is 200 mcg.
It has a half-life of 10-14 hours, while some of its effects last much longer, which is why it is advised to cycle it. One can choose to either take it every 2nd day, or twice a week.